Literature DB >> 11155441

Dendritic cell biology and regulation of dendritic cell trafficking by chemokines.

C Caux1, S Ait-Yahia, K Chemin, O de Bouteiller, M C Dieu-Nosjean, B Homey, C Massacrier, B Vanbervliet, A Zlotnik, A Vicari.   

Abstract

DC (dendritic cells) represent an heterogeneous family of cells which function as sentinels of the immune system. They traffic from the blood to the tissues where, while immature, they capture antigens. Then, following inflammatory stimuli, they leave the tissues and move to the draining lymphoid organs where, converted into mature DC, they prime naive T cells. The key role of DC migration in their sentinel function led to the investigation of the chemokine responsiveness of DC populations during their development and maturation. These studies have shown that immature DC respond to many CC and CXC chemokines (MIP-1 alpha, MIP-1 beta, MIP-3 alpha, MIP-5, MCP-3, MCP-4, RANTES, TECK and SDF-1) which are inducible upon inflammatory stimuli. Importantly, each immature DC population displays a unique spectrum of chemokine responsiveness. For examples, Langerhans cells migrate selectively to MIP-3 alpha (via CCR6), blood CD11c+ DC to MCP chemokines (via CCR2), monocytes derived-DC respond to MIP-1 alpha/beta (via CCR1 and CCR5), while blood CD11c- DC precursors do not respond to any of these chemokines. All these chemokines are inducible upon inflammatory stimuli, in particular MIP-3 alpha, which is only detected within inflamed epithelium, a site of antigen entry known to be infiltrated by immature DC. In contrast to immature DC, mature DC lose their responsiveness to most of these inflammatory chemokines through receptor down-regulation or desensitization, but acquire responsiveness to ELC/MIP-3 beta and SLC/6Ckine as a consequence of CCR7 up-regulation. ELC/MIP-3 beta and SLC/6Ckine are specifically expressed in the T-cell-rich areas where mature DC home to become interdigitating DC. Altogether, these observations suggest that the inflammatory chemokines secreted at the site of pathogen invasion will determine the DC subset recruited and will influence the class of the immune response initiated. In contrast, MIP-3 beta/6Ckine have a determinant role in the accumulation of antigenloaded mature DC in T cell-rich areas of the draining lymph node, as illustrated by recent observations in mice deficient for CCR7 or SLC/6Ckine. A better understanding of the regulation of DC trafficking might offer new opportunities of therapeutic interventions to suppress, stimulate or deviate the immune response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11155441     DOI: 10.1007/s002810000053

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN: 0344-4325


  123 in total

1.  Distinct patterns and kinetics of chemokine production regulate dendritic cell function.

Authors:  F Sallusto; B Palermo; D Lenig; M Miettinen; S Matikainen; I Julkunen; R Forster; R Burgstahler; M Lipp; A Lanzavecchia
Journal:  Eur J Immunol       Date:  1999-05       Impact factor: 5.532

2.  A new class of membrane-bound chemokine with a CX3C motif.

Authors:  J F Bazan; K B Bacon; G Hardiman; W Wang; K Soo; D Rossi; D R Greaves; A Zlotnik; T J Schall
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

3.  Down-regulation of the beta-chemokine receptor CCR6 in dendritic cells mediated by TNF-alpha and IL-4.

Authors:  L Carramolino; L Kremer; I Goya; R Varona; J M Buesa; J Gutiérrez; A Zaballos; C Martínez-A; G Márquez
Journal:  J Leukoc Biol       Date:  1999-11       Impact factor: 4.962

4.  Fractalkine and macrophage-derived chemokine: T cell-attracting chemokines expressed in T cell area dendritic cells.

Authors:  N Kanazawa; T Nakamura; K Tashiro; M Muramatsu; K Morita; K Yoneda; K Inaba; S Imamura; T Honjo
Journal:  Eur J Immunol       Date:  1999-06       Impact factor: 5.532

Review 5.  Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines.

Authors:  M C Dieu-Nosjean; A Vicari; S Lebecque; C Caux
Journal:  J Leukoc Biol       Date:  1999-08       Impact factor: 4.962

6.  A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1)

Authors:  C C Bleul; R C Fuhlbrigge; J M Casasnovas; A Aiuti; T A Springer
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

7.  Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s.

Authors:  R Bonecchi; G Bianchi; P P Bordignon; D D'Ambrosio; R Lang; A Borsatti; S Sozzani; P Allavena; P A Gray; A Mantovani; F Sinigaglia
Journal:  J Exp Med       Date:  1998-01-05       Impact factor: 14.307

8.  Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells.

Authors:  V N Ngo; H L Tang; J G Cyster
Journal:  J Exp Med       Date:  1998-07-06       Impact factor: 14.307

9.  The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand.

Authors:  G Grouard; M C Rissoan; L Filgueira; I Durand; J Banchereau; Y J Liu
Journal:  J Exp Med       Date:  1997-03-17       Impact factor: 14.307

Review 10.  Mobilizing dendritic cells for tolerance, priming, and chronic inflammation.

Authors:  F Sallusto; A Lanzavecchia
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more
  72 in total

1.  Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.

Authors:  M Pashenkov; N Teleshova; M Kouwenhoven; V Kostulas; Y-M Huang; M Soderstrom; H Link
Journal:  Clin Exp Immunol       Date:  2002-03       Impact factor: 4.330

2.  Systemic treatment with anti-CD40 antibody stimulates Langerhans cell migration from the skin.

Authors:  S Jolles; J Christensen; M Holman; G B Klaus; A Ager
Journal:  Clin Exp Immunol       Date:  2002-09       Impact factor: 4.330

3.  Mycobacterium bovis BCG cell wall-specific differentially expressed genes identified by differential display and cDNA subtraction in human macrophages.

Authors:  Nasim A Begum; Kazuo Ishii; Mitsue Kurita-Taniguchi; Masako Tanabe; Mika Kobayashi; Yasuhiro Moriwaki; Misako Matsumoto; Yasuo Fukumori; Ichiro Azuma; Kumao Toyoshima; Tsukasa Seya
Journal:  Infect Immun       Date:  2004-02       Impact factor: 3.441

4.  Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells.

Authors:  Jone Garay; June A D'Angelo; YongKeun Park; Christopher M Summa; Martha L Aiken; Eric Morales; Kamran Badizadegan; Edda Fiebiger; Bonny L Dickinson
Journal:  J Immunol       Date:  2010-08-20       Impact factor: 5.422

5.  Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation.

Authors:  Christoph H Schimmelpfennig; Stephan Schulz; Caroline Arber; Jeanette Baker; Ingo Tarner; Jacqueline McBride; Christopher H Contag; Robert S Negrin
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 6.  Human dendritic cell subsets for vaccination.

Authors:  Peter Dubsky; Hideki Ueno; Bernard Piqueras; John Connolly; Jacques Banchereau; A Karolina Palucka
Journal:  J Clin Immunol       Date:  2005-11       Impact factor: 8.317

7.  Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors.

Authors:  J Diana; C Vincent; F Peyron; S Picot; D Schmitt; F Persat
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

8.  Targeting the intratumoral dendritic cells by the oncolytic adenoviral vaccine expressing RANTES elicits potent antitumor immunity.

Authors:  Natalia Lapteva; Melissa Aldrich; David Weksberg; Lisa Rollins; Tatiana Goltsova; Si-Yi Chen; Xue F Huang
Journal:  J Immunother       Date:  2009 Feb-Mar       Impact factor: 4.456

9.  Genetic profiling of dendritic cells exposed to live- or ultraviolet-irradiated Chlamydia muridarum reveals marked differences in CXC chemokine profiles.

Authors:  Michelle L Zaharik; Tarun Nayar; Rick White; Caixia Ma; Bruce A Vallance; Nadine Straka; Xiaozhou Jiang; Jose Rey-Ladino; Caixia Shen; Robert C Brunham
Journal:  Immunology       Date:  2006-10-31       Impact factor: 7.397

10.  Stromal-derived factor-1alpha (CXCL12) levels increase in periodontal disease.

Authors:  Aaron M Havens; Evonne Chiu; Mario Taba; Jincheng Wang; Yusuke Shiozawa; Younghun Jung; L Susan Taichman; Nisha J D'Silva; R Gopalakrishnan; CunYu Wang; William V Giannobile; Russell S Taichman
Journal:  J Periodontol       Date:  2008-05       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.